Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut 
Unifor Reaches Tentative GM Deal for 4,600 Ontario Workers 
SpaceX Hires Natural Gas Trader to Meet Growing Energy Needs 
SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme 
Hyundai Motor Union Launches First Full Strike in Decade Over Wages, AI Job Risks 
Welspun Corp Shares Hit Record High on $1.8 Billion U.S. Order 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
TikTok, DOJ Reach $400 Million Children’s Privacy Settlement 
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports 
Alibaba Shares Fall as AI Spending Hits Profit 
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Add as a preferred source on Google
BURLINGTON, Mass., May 03, 2018 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will be presenting in three conferences in May.
David Roberts, President, is scheduled to present at the Deutsche Bank Healthcare Conference on Tuesday, May 8, 2018 at the InterContinental Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 10:40 AM EDT.
George LeMaitre, Chairman & CEO, is scheduled to present at the East Coast IDEAS Conference on Wednesday, May 9, 2018 at the Boston Park Plaza Hotel in Boston, MA. The Company’s presentation is scheduled to begin at 11:10 AM EDT.
David Roberts, President, is scheduled to present at the UBS Healthcare Conference on Tuesday, May 22, 2018 at the Grand Hyatt New York Hotel in New York City. The Company’s presentation is scheduled to begin at 3:30 PM EDT.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc.
Investor Relations
Steven Chehames
+1-781-425-1659
[email protected]
